Search
Selected Filter
Displaying 21–30 of 347 diseases results
-
Editas Reports Results for 14 Participants in its Phase 1/2 CRISPR/Cas9 Clinical Trial for LCA10
Eye On the Cure Research NewsThe company is seeking a partner to move the LCA10 program forward
-
Chloe’s Creative Journey with Vision Loss
Beacon StoriesChloé Duplessis is a legally blind digital collage artist in Denver, Colorado. At 39 years old, Chloé was diagnosed with Stargardt disease, which was a pivotal point in her creative journey to becoming a full-time artist and owner of Duplessis Art.
-
Press Releases
Uni-Rare Study will improve clinical understanding of more IRDs and boost development of potential therapies.
-
Charlie Kramer: Life Coach for the Disabled
Beacon StoriesRetinitis pigmentosa (RP) runs in Charlie Kramer’s family, so it wasn’t a surprise when he was diagnosed at a young age. But now, at 29 years old, Charlie is following his passion for helping and empowering others as a full-time life coach for those with disabilities.
-
The Foundation in the News
On World Sight Day 2022, Retina International is presenting data from a report on its study into the Socio-economic Impact of late-stage age-related macular degeneration (AMD) in Bulgaria, Germany, and USA.
-
Atsena’s LCA-GUCY2D Gene Therapy Improves Vision in Phase 1/2 Clinical Trial
Eye On the Cure Research NewsThe company is planning to move the emerging treatment into a pivotal trial
-
RD Fund Participates in a €75 Million Series B for SparingVision
The Foundation in the NewsProceeds to fund first, in-human trials of breakthrough gene-agnostic therapy products and advance CRISPR-based genome editing portfolio.
-
Iveric Bio’s Zimura for Advanced Dry AMD Meets Endpoint in Second Phase 3 Clinical Trial
Eye On the Cure Research NewsThe company plans to seek FDA approval for the emerging therapy in first quarter of 2023
-
Belite Bio Launching Phase 3 Clinical Trial for Stargardt Disease Drug
Eye On the Cure Research NewsThe company’s drug is designed to reduce accumulation of toxins that cause vision loss.
-
Decades of Dedication Fighting for His Family and Himself
Beacon StoriesDan Day is one of over ten people in his family, spanning six generations, affected with retinitis pigmentosa (RP). So to “get off the sidelines and join the fight” for himself and his family, Dan has dedicated over 25 years of service to the Foundation Fighting Blindness.
